Caseware UK (AP4) 2022.0.179 2022.0.179 2023-06-302023-06-30falseNo description of principal activity2022-07-0122truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12075637 2022-07-01 2023-06-30 12075637 2021-07-01 2022-06-30 12075637 2023-06-30 12075637 2022-06-30 12075637 c:Director1 2022-07-01 2023-06-30 12075637 c:Director1 2022-07-01 12075637 c:Director1 2023-06-30 12075637 c:Director2 2022-07-01 2023-06-30 12075637 d:PlantMachinery 2022-07-01 2023-06-30 12075637 d:PlantMachinery 2023-06-30 12075637 d:PlantMachinery 2022-06-30 12075637 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-07-01 2023-06-30 12075637 d:FurnitureFittings 2022-07-01 2023-06-30 12075637 d:FurnitureFittings 2023-06-30 12075637 d:FurnitureFittings 2022-06-30 12075637 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-07-01 2023-06-30 12075637 d:OfficeEquipment 2022-07-01 2023-06-30 12075637 d:OfficeEquipment 2023-06-30 12075637 d:OfficeEquipment 2022-06-30 12075637 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-07-01 2023-06-30 12075637 d:OwnedOrFreeholdAssets 2022-07-01 2023-06-30 12075637 d:CurrentFinancialInstruments 2023-06-30 12075637 d:CurrentFinancialInstruments 2022-06-30 12075637 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 12075637 d:CurrentFinancialInstruments d:WithinOneYear 2022-06-30 12075637 d:ShareCapital 2023-06-30 12075637 d:ShareCapital 2022-06-30 12075637 d:RetainedEarningsAccumulatedLosses 2023-06-30 12075637 d:RetainedEarningsAccumulatedLosses 2022-06-30 12075637 c:FRS102 2022-07-01 2023-06-30 12075637 c:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 12075637 c:FullAccounts 2022-07-01 2023-06-30 12075637 c:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 12075637 2 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure

Registered number: 12075637










JAMES SURGICAL LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2023

 
JAMES SURGICAL LIMITED
REGISTERED NUMBER: 12075637

BALANCE SHEET
AS AT 30 JUNE 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 5 
1,128
1,503

  
1,128
1,503

Current assets
  

Debtors: amounts falling due within one year
 6 
104,395
110,504

Cash at bank and in hand
  
261,899
192,172

  
366,294
302,676

Creditors: amounts falling due within one year
 7 
(54,662)
(44,237)

Net current assets
  
 
 
311,632
 
 
258,439

Total assets less current liabilities
  
312,760
259,942

  

Net assets
  
312,760
259,942


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
312,660
259,842

  
312,760
259,942


Page 1

 
JAMES SURGICAL LIMITED
REGISTERED NUMBER: 12075637
    
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 

Christopher James
Kirsty Montague James
Director
Director


Date: 11 April 2024
Date:11 April 2024

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
JAMES SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

1.


General information

James Surgical Limited is a private company limited by shares incorporated in England and Wales in the United Kingdom. The address of the registered office is Victoria Court, 17-21 Ashford Road, Maidstone, Kent, ME14 5DA.
The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

Page 3

 
JAMES SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
JAMES SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)


2.8
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Medical equipment
-
25%
Fixtures and fittings
-
25%
Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
JAMES SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

2.Accounting policies (continued)

 
2.12

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Judgments in applying accounting policies and key sources of estimation uncertainty

No significant judgements have been made by management in preparing these financial statements.


4.


Employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2).

Page 6

 
JAMES SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

5.


Tangible fixed assets





Medical equipment
Fixtures and fittings
Office equipment
Total

£
£
£
£



Cost or valuation


At 1 July 2022
400
1,090
1,216
2,706



At 30 June 2023

400
1,090
1,216
2,706



Depreciation


At 1 July 2022
231
385
587
1,203


Charge for the year on owned assets
42
176
157
375



At 30 June 2023

273
561
744
1,578



Net book value



At 30 June 2023
127
529
472
1,128



At 30 June 2022
169
705
629
1,503


6.


Debtors

2023
2022
£
£


Trade debtors
49,114
53,125

Other debtors
37,633
41,418

Prepayments and accrued income
17,648
15,961

104,395
110,504


Page 7

 
JAMES SURGICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023

7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Corporation tax
50,524
41,903

Other creditors
1,888
563

Accruals and deferred income
2,250
1,771

54,662
44,237



8.


Pension commitments

The company operated a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £40,000 (2022 - £12,000). Contributions totalling £Nil (2022 - £Nil) were payable to the fund at the balance sheet date.


9.


Related party transactions

As at the balance sheet date the directors owed the company £27,416 (2022: £31,207) which is included within other debtors. Interest at 2.5% has been charged on the loan balance.

 
Page 8